Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
bayer
2
×
biogen
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aducanumab
adverum biotechnologies
affordable care act
albert bourla
aldeyra therapeutics
alex azar
What
bio
drug
2
×
roundup
acquisitions
aducanumab
albert
alzheimer’s
amyloid
angst
bagged
biggest
billions
biogen
biogen’s
bourla
brammer
ceo
company
crispr
effects
failure
felt
future
imports
lost
maker
maps
measured
nash
news
patients
pfizer
pfizer’s
revenue
ripple
today
week
world’s
Language
unknown
Current search:
bayer
×
drug
×
biogen
×
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More